CRISPR-X Trademark
CRISPR-X is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Pending.
Trademark Facts
| Mark | CRISPR-X |
|---|---|
| Serial Number | 99555280 |
| Status | Pending |
| Filing Date | 2025-12-18 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 7 |
| Latest Event | GNRT on 2026-04-28 |
Goods & Services
Class 042: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-28 | Notice of Non-Final Office Action | NFO |
| 2026-04-28 | Non-Final Action | NFIN |